Three-Generation Risk Review
The visit maps pancreatitis, unexplained pancreatic disease, diabetes, and pancreatic cancer across close relatives instead of relying on a single yes-or-no family-history question.

Connect recurrent pancreatitis, a PRSS1 result, and your family history to one long-term plan. GastroDoxs helps Houston patients organize diagnosis, complication monitoring, and referrals when specialized pancreas care is needed.
GastroDoxs GutRescue Mission™ gives Houston, TX patients a structured pathway for hereditary pancreatitis—confirming what the genetic result means, separating inherited disease from other pancreatitis causes, and planning care across attacks, nutrition, pancreatic function, and family risk.
GastroDoxs GutRescue Mission™ gives Houston, TX patients a structured pathway for hereditary pancreatitis—confirming what the genetic result means, separating inherited disease from other pancreatitis causes, and planning care across attacks, nutrition, pancreatic function, and family risk.
Classic PRSS1-related hereditary pancreatitis often causes acute attacks beginning early in life and may progress to chronic pancreatitis. SPINK1, CFTR, CTRC, CPA1, and other variants can also influence susceptibility, but the clinical meaning depends on the exact variant, inheritance pattern, symptoms, and other risk factors.
A Houston evaluation can coordinate gastroenterology, genetic counseling, pancreatic imaging or function testing, nutrition, endocrinology, advanced endoscopy, surgery, or a high-risk surveillance program when the evidence supports those services. The goal is not to order every test locally; it is to build the right sequence and referral plan.
One clinical plan for attacks, genetics, relatives, and long-term risk
The visit maps pancreatitis, unexplained pancreatic disease, diabetes, and pancreatic cancer across close relatives instead of relying on a single yes-or-no family-history question.
The exact laboratory classification—pathogenic, likely pathogenic, risk variant, or variant of uncertain significance—is considered before a hereditary diagnosis or testing plan is assigned to relatives.
Nutrition, genetics, endocrinology, advanced endoscopy, pancreatic surgery, pain support, or a high-risk program is added when a defined problem requires that expertise.
Follow-up tracks recurrent attacks, exocrine pancreatic insufficiency, nutrient loss, diabetes, duct complications, and pancreatic cancer risk without treating routine testing as one-size-fits-all.
GastroDoxs provides GI evaluation and coordination. Genetic counseling, cancer surveillance, advanced procedures, and surgery may require referral to the appropriate program or facility.
Your guardians. GastroDoxs GutGuardians™ is our team of gastroenterologists board-certified by the American Board of Internal Medicine (ABIM) - a physician-led defense force of specialists, systems, and solution pathways working together to protect, detect, solve, and defend your digestive health through expert GI evaluation, advanced diagnostic screening, and endoscopic evaluation - commanded from your first concern to your last follow-up, and every critical stage in between.
Your rescue plan. When your diagnosis is confirmed, GastroDoxs GutRescue Mission™ deploys at full force - a gastroenterologist-led intervention plan delivering advanced colonoscopy, upper endoscopy, capsule endoscopy, and precision biologic and medication management across the full range of digestive conditions and complex GI emergencies - fighting for you with everything we have.
Use the map and visit details below to plan your appointment at the GastroDoxs office near Houston.
Genetic risk deserves specialist context when pancreatitis is documented or repeatedly unexplained.
Two or more documented acute attacks—especially without a clear gallstone, medication, metabolic, or alcohol explanation—can justify a genetic and structural review.
Pancreatic calcification, duct change, atrophy, or exocrine dysfunction at a young age raises the value of a detailed inherited-risk evaluation.
A pathogenic or likely pathogenic gain-of-function PRSS1 result should be matched with the person’s pancreatitis history, penetrance, and implications for close relatives.
A pattern involving a parent, child, sibling, aunt, uncle, or grandparent may point to familial disease even when family members received different labels.
Steatorrhea, diarrhea, bloating, weight loss, or vitamin deficiency may indicate exocrine pancreatic insufficiency that needs testing and treatment.
Diabetes after pancreatic injury and questions about pancreatic cancer screening require a risk-based plan, not unscheduled CT scans or blood tests alone.
Severe persistent upper-abdominal pain, repeated vomiting, fainting, breathing difficulty, fever with rapid decline, jaundice, or dehydration needs urgent medical assessment rather than a routine office appointment.
Bring the records that prove attacks, identify the variant, and show how the pancreas has changed.
Note which relatives had pancreatitis, pancreatic surgery, pancreatic cancer, unexplained diabetes, recurrent severe abdominal pain, or a known genetic result, including approximate ages.
Bring emergency and hospital summaries, lipase results, CT or MRI reports, discharge diagnoses, and dates of episodes rather than relying only on memory.
Include the laboratory, gene, exact variant, classification, testing date, and any genetic counselor interpretation; a patient-portal summary may omit decisive details.
Record enzyme dose and timing, pain medicines, supplements, alcohol and tobacco exposure, weight changes, stool symptoms, and glucose results so modifiable risks and complications can be addressed.
Do not stop pancreatic enzymes, diabetes medicine, or prescribed pain treatment before the visit unless the prescribing clinician tells you to do so.
Clarify separate benefits for genetics, imaging, surveillance, and procedures.
Coverage varies by plan, diagnosis, facility, and network. The insurer—not GastroDoxs—makes the final benefit determination.
Ask whether counseling is required before a pancreatitis panel, whether a specific laboratory is preferred, and whether testing an affected relative first changes coverage.
If PRSS1-related risk supports surveillance, confirm the program, specialist, MRI/MRCP or EUS authorization, and age or interval requirements before scheduling.
ERCP, EUS, celiac plexus intervention, surgery, anesthesia, pathology, and facility charges may be separate and should be verified for the recommended site.
When care is shared with a Houston pancreas center, confirm referral rules and obtain both the specialist and facility network status rather than assuming they are identical.
Answers about genes, family risk, treatment, surveillance, and Houston access
Classic autosomal-dominant hereditary pancreatitis is most often linked to a pathogenic gain-of-function PRSS1 variant. Other genes, including SPINK1, CFTR, CTRC, and CPA1, may cause or modify susceptibility, but their interpretation is variant- and context-specific.
Many SPINK1 findings increase susceptibility rather than independently proving classic hereditary pancreatitis. The exact variant, whether one or two copies are present, other genetic factors, exposures, and the person’s documented pancreatitis history all matter.
A gastroenterologist usually coordinates pancreatic care. Genetic counseling, nutrition, endocrinology, advanced endoscopy, pancreatic surgery, pain care, or a high-risk surveillance program may be added for specific needs.
Diagnosis combines documented acute, recurrent acute, or chronic pancreatitis with family history, exclusion of other causes, and clinically appropriate genetic testing. A risk variant or variant of uncertain significance should not be treated as a definitive diagnosis by itself.
A person with an autosomal-dominant pathogenic PRSS1 variant has a 50% chance of passing that variant to each child. Inheritance does not predict the exact age, attack frequency, or severity because penetrance and expression vary.
There is no medicine that removes the inherited predisposition. Care can treat acute attacks and complications, protect nutrition and glucose control, address duct problems, and reduce avoidable risks; selected patients with severe disease may be evaluated for major surgery.
Certain forms, especially PRSS1-related hereditary pancreatitis, increase risk. Screening should be discussed with an experienced high-risk program; it is not the same as ordering routine CT scans or relying on a tumor-marker blood test.
Timing depends on the gene, pancreatitis history, age, family history, and current expert guidance. PRSS1 carriers with hereditary pancreatitis are often considered for specialized surveillance beginning around age 40, but the program should individualize the start and tests.
Coffee is not a universal hereditary-pancreatitis trigger. Some people notice that caffeine, large portions, high-fat foods, or dehydration worsen symptoms; keep a pattern log and review it without replacing the more important advice to avoid tobacco and alcohol.
There is no single newest treatment for everyone. Modern care matches pancreatic enzymes, nutrition, pain therapy, endoscopic treatment for selected obstruction, and surgery—including total pancreatectomy with islet autotransplantation for carefully selected severe cases—to the disease pattern.
Yes, but genetic counseling is valuable. When a familial pathogenic variant is known, targeted testing may be more informative than a broad panel; testing an affected relative first may also clarify what an unaffected relative’s result can mean.
Seek urgent evaluation for severe persistent upper-abdominal pain, repeated vomiting, fainting, marked dehydration, shortness of breath, confusion, jaundice, or fever with rapid worsening. Acute pancreatitis can require hospital care.
Those symptoms may reflect exocrine pancreatic insufficiency. Testing can support the diagnosis, and prescribed pancreatic enzyme replacement taken during meals or snacks can improve digestion; nutrition and vitamin status may also need review.
Not automatically. ERCP is mainly therapeutic when a pancreatic or bile duct obstruction, stone, leak, or other treatable duct problem is present. MRI/MRCP or EUS may be used first depending on the question.
Houston patients can schedule at 10425 Huffmeister Road, Suite 280, Houston, TX 77065, near Jersey Village. This service-area page does not claim a separate downtown or Memorial office.
Call GastroDoxs at 832-632-4070 or schedule online. Tell the team whether you have a genetic report, prior hospitalizations, outside imaging, or a family pancreatic-cancer history so record instructions can be provided before the visit.
If recurrent pancreatitis or a genetic result affects several members of your family, schedule a Houston-area GI review. Bring the complete evidence so the next step—local management, family counseling, or specialized referral—matches the actual risk.